A new mini review was published in Oncotarget's Volume 15 on September 30, 2024, entitled, "Linking FOXM1 and PD-L1 to CDK4/6 ...

We suggest that future therapeutic strategies targeting the oncogenic network of CDK4/6, MEK, PD-L1, and FOXM1 represent ...

PD-1抑制剂在胃癌治疗中的使用将迎变局。9月26日，FDA召开了一场肿瘤咨询委员会（ODAC），主要讨论是否应当根据PD-L1表达水平，对PD-1抑制剂在胃癌及食管癌中的使用加以限制。涉及默沙东K药、BMS的O药、百济神州替雷利珠单抗三款药物。20 ...

经济观察网 记者 瞿依贤 北京时间9月27日，美国食品药品监督管理局（FDA）肿瘤药物专家咨询委员会（ODAC）的一场会议结束，历时9个小时。这场会议的讨论结果可能让国内外的PD-1类药物市场大变。

Immune checkpoint inhibitors industry is projected to witness a CAGR of 16.7% during the period 2024-2032. This growth can be ...

9 月已经结束。根据 Insight 数据库，有 9 款为抗肿瘤新药在九月向 CDE 递交了上市申请，包括 4 个新药的首次 NDA 和 5 款新药的新适应症/新剂型 NDA，适应症涉及鼻咽癌、大 B ...

WARMINSTER, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage ...

Shattuck Labs (STTK – Research Report) received a Hold rating and price target from H.C. Wainwright analyst Joseph Pantginis today. The ...

Analyst Charles Zhu of LifeSci Capital maintained a Buy rating on Merus (MRUS – Research Report), retaining the price target of $100.00.

长圣(6712)受惠于CDMO服务与全台19家医疗机构合作，自结9 月营收以9,002万元再创新高，连续9个月长红，累计前九月营收达5.89 亿元，年增率高达17.16％，再次刷新同期新高纪录，预期第四季营收将更好。总经理黄文良表 ...

A high density of tumor-associated macrophages (TAMs) is associated with poorer prognosis and survival in breast cancer patients. Recent studies have shown that lipid accumulation in TAMs can promote ...

Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...